Evidence map›Paper›PMID 34584177›Full record

Observational studyScientific reports2021

Adults with Crohn's disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission.

Lisa Dowling, Philip Jakeman, Catherine Norton, Maeve M Skelly, Hamid Yousuf, Miranda G Kiernan, Margaret Toomey, Sheila Bowers, Suzanne S Dunne, J Calvin Coffey and 1 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Infliximab modifies CD74-mediated lymphatic abnormalities and adipose tissue alterations in creeping fat of Crohn's disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  3. Article
  4. Review
  5. Feasibility ofQuantitative imaging in medicine and surgery · 2023
    Article
  6. Body Composition in Inflammatory Bowel Disease.Archives of Iranian medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lisa DowlingCentre for Interventions in Infection, Inflammation and Immunity (4i), Limerick, Ireland.
Philip JakemanCentre for Interventions in Infection, Inflammation and Immunity (4i), Limerick, Ireland.
Catherine NortonPhysical Education and Sports Sciences, University of Limerick, Limerick, Ireland.
Maeve M SkellySchool of Medicine, University of Limerick, Limerick, Ireland.
Hamid YousufDepartment of Gastroenterology, University Limerick Hospital Group, Limerick, Ireland.
Miranda G KiernanSchool of Medicine, University of Limerick, Limerick, Ireland.
Margaret ToomeySchool of Medicine, University of Limerick, Limerick, Ireland.
Sheila BowersDepartment of Dietetics, University Limerick Hospital Group, Limerick, Ireland.
Suzanne S DunneCentre for Interventions in Infection, Inflammation and Immunity (4i), Limerick, Ireland.
J Calvin CoffeyCentre for Interventions in Infection, Inflammation and Immunity (4i), Limerick, Ireland.
Colum P DunneCentre for Interventions in Infection, Inflammation and Immunity (4i), Limerick, Ireland. colum.dunne@ul.ie.
University of Limerick · IEUniversity Hospital Limerick · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease (CD) is a debilitating inflammatory bowel condition of unknown aetiology that is growing in prevalence globally. Large-scale studies have determined associations between female obesity or low body mass index (BMI) with risk of CD at all ages or 8- < 40 years, respectively. For males, low BMI entering adult life is associated with increased incidence of CD or ulcerative colitis up to 40 years later. Body composition analysis has shown that combinations of lean tissue loss and high visceral fat predict poor CD outcomes. Here, we assessed dietary intake, physical activity and whole or regional body composition of patients with CD relapse or remission. This anthropometric approach found people with CD, irrespective of relapse or remission, differed from a large representative healthy population sample in exhibiting elevated gynoid fat and reduced android fat. CD is associated with mesenteric adipose tissue, or "creeping fat", that envelops affected intestine exclusive of other tissue; that fat is localised to the android region of the body. In this context, CD mesenteric adiposity represents a stark juxtaposition of organ-specific and regional adiposity. Although our study population was relatively small, we suggest tentatively that there is a rationale to refer to Crohn's disease as a fatty intestine condition, akin to fatty liver conditions. We suggest that our data provide early insight into a subject that potentially warrants further investigation across a larger patient cohort.

Indexed as

Absorptiometry, PhotonAdiposityAdultBody Mass IndexCrohn DiseaseDiet SurveysEnergy MetabolismFemaleHumansMaleMiddle AgedProspective StudiesRecurrence

Identifiers

PMID34584177
PMCPMC8479075
OpenAlexW3204620601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.